newsfilter
← Latest News
ACCESS Newswire·

Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine

SAN FRANCISCO, CA / ACCESSWIRE / February 14, 2022 / Oncology Pharma, Inc. ("The Company") (OTC:ONPH) and Regen BioPharma, Inc. (OTC:RGBP) and (OTC:RGBPP): announced that they intend to work jointly to fast track the development of therapeutic uses relat